Dose Cancer Research Results
Dose, Dosage: Click to Expand ⟱
| Source: |
| Type: |
Drug dosage vs efficacy, and actual dosage number of research papers.
|
CRC, Colorectal Cancer: Click to Expand ⟱
Colorectal cancer is a broader term that encompasses both colon and rectal cancer.
|
Scientific Papers found: Click to Expand⟱
| - |
in-vitro, |
CRC, |
DLD1 |
|
|
|
- |
NA, |
NA, |
HCT116 |
|
|
|
eff↑, Ferroptosis↓, TumAuto↑, Apoptosis↑, FOXO3↑, AMPKα↑, p‑Beclin-1↑, HK2↓, ATP↓, ROS↑, Dose↝, TumVol↓, TumW↓, xCT↑, GSH↓, eff↓, MDA↑,
Risk↓, Dose↝, Risk↓,
Risk↓, other↝, Dose↝, Risk↓, other↓, other↝, KRAS↓, other↓, other↓,
Dose↝, OS∅,
Dose↝, Risk↓,
| - |
vitro+vivo, |
CRC, |
HCT116 |
|
|
|
angioG↓, VEGF↓, TumVol↓, HSPD1 / HSP60↓, HTRA↓, survivin↓, XIAP↓, P21↑, TumCP↓, TumCMig↓, TumCG↓, Dose↝,
| - |
in-vitro, |
CRC, |
HCT116 |
|
|
|
- |
in-vitro, |
CRC, |
SW480 |
|
|
|
tumCV↓, HSP70/HSPA5⇅, ROS↑, cl‑Casp3↑, mt-Apoptosis↑, Dose↝,
Dose↝, *DNArepair↑, toxicity↝, BioAv↝, eff∅,
| - |
vitro+vivo, |
CRC, |
HCT116 |
|
|
|
- |
in-vitro, |
CRC, |
SW480 |
|
|
|
- |
in-vitro, |
CRC, |
LoVo |
|
|
|
Dose↝, TumCP↓, selectivity↑, MMP↓, Apoptosis↑, TumCCA↑, NF-kB↓, CDK4↓, cycD1/CCND1↓, Casp9↑, Casp3↑, Bax:Bcl2↑, TumCG↓, ChemoSen↑, TNF-α↓, IL1β↓, P53↑, P21↑,
| - |
Review, |
CRC, |
NA |
|
|
|
- |
Review, |
HNSCC, |
NA |
|
|
|
EGFR↓, OS↑, QoL↑, Dose↝,
eff↑, Dose↝,
| - |
vitro+vivo, |
CRC, |
HCT116 |
|
|
|
- |
NA, |
Nor, |
NCM460 |
|
|
|
TumCD↑, Apoptosis↑, Casp8↑, selectivity↑, TumCMig↓, selectivity↑, Dose↝, toxicity↓, TumCG↓, MMP↓, mt-ROS↑, *ROS↓, BID↑, Bcl-2↓, PARP↓, NF-kB↑, *NF-kB↓, Casp1↑, *Casp1↓, COX2↑, OXPHOS↓, ETC↓,
eff↑, ChemoSen↑, HSP90↓, Dose↝, TumAuto↑, Apoptosis↑, PI3K↓, Akt↓, mTOR↓, JNK↓, p38↓, EMT↓,
| - |
vitro+vivo, |
CRC, |
SW480 |
|
|
|
- |
in-vitro, |
CRC, |
HT29 |
|
|
|
AntiTum↑, *Inflam↓, *antiOx↓, TumCP↓, BAX↑, Casp3↑, Casp9↑, Bcl-2↓, TumCMig↓, TumCI↓, MMP2↓, MMP9↓, p‑PI3K↓, p‑Akt↓, Dose↝, TumCG↓,
PGC-1α↑, Dose↝, CD8+↑, OS↑,
| - |
in-vivo, |
BC, |
MDA-MB-231 |
|
|
|
- |
in-vitro, |
CRC, |
HCT116 |
|
|
|
e-pH↑, TumCG↓, TumCI↓, Dose↝,
Risk↓, selm↑, Dose↓, antiOx↑, Dose↑, Dose↝,
Risk↓, Dose↝,
| - |
in-vitro, |
CRC, |
HCT8 |
|
|
|
- |
in-vivo, |
NA, |
NA |
|
|
|
chemoP↑, ChemoSen↑, P53↑, Apoptosis↑, TumCG↓, Casp↑, Dose↝, NRF2↓, selectivity↑, *NRF2↑,
| - |
in-vitro, |
CRC, |
HCT116 |
|
|
|
- |
in-vitro, |
Liver, |
HepG2 |
|
|
|
- |
in-vitro, |
BC, |
MCF-7 |
|
|
|
Dose↝, AntiCan↑, eff↑,
| - |
in-vitro, |
CRC, |
T24/HTB-9 |
|
|
|
Dose↝, NRF2↑, GSH↓, eff↑,
| - |
in-vitro, |
lymphoma, |
U937 |
|
|
|
- |
in-vitro, |
BC, |
MCF-7 |
|
|
|
- |
in-vitro, |
BC, |
SkBr3 |
|
|
|
- |
in-vitro, |
CRC, |
HCT116 |
|
|
|
- |
in-vitro, |
OS, |
U2OS |
|
|
|
- |
NA, |
Nor, |
RPE-1 |
|
|
|
tumCV↓, selectivity↑, Dose↝, other↑, MMP↓, ROS↑, DNAdam↑, Ca+2↑, Casp9↑, Cyt‑c↑, *toxicity↓,
GutMicro↑, Dose↝, IL1β↓, IL6↓, TNF-α↓, PKM2↓,
Showing Research Papers: 1 to 23 of 23
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 23
Pathway results for Effect on Cancer / Diseased Cells:
NA, unassigned ⓘ
HSPD1 / HSP60↓, 1, HTRA↓, 1,
Redox & Oxidative Stress ⓘ
antiOx↑, 1, Ferroptosis↓, 1, GSH↓, 2, MDA↑, 1, NRF2↓, 1, NRF2↑, 1, OXPHOS↓, 1, ROS↑, 3, mt-ROS↑, 1, xCT↑, 1,
Metal & Cofactor Biology ⓘ
selm↑, 1,
Mitochondria & Bioenergetics ⓘ
ATP↓, 1, ETC↓, 1, MMP↓, 3, PGC-1α↑, 1, XIAP↓, 1,
Core Metabolism/Glycolysis ⓘ
HK2↓, 1, PKM2↓, 1,
Cell Death ⓘ
Akt↓, 1, p‑Akt↓, 1, Apoptosis↑, 5, mt-Apoptosis↑, 1, BAX↑, 1, Bax:Bcl2↑, 1, Bcl-2↓, 2, BID↑, 1, Casp↑, 1, Casp1↑, 1, Casp3↑, 2, cl‑Casp3↑, 1, Casp8↑, 1, Casp9↑, 3, Cyt‑c↑, 1, Ferroptosis↓, 1, JNK↓, 1, p38↓, 1, survivin↓, 1, TumCD↑, 1,
Kinase & Signal Transduction ⓘ
AMPKα↑, 1,
Transcription & Epigenetics ⓘ
other↓, 3, other↑, 1, other↝, 2, tumCV↓, 2,
Protein Folding & ER Stress ⓘ
HSP70/HSPA5⇅, 1, HSP90↓, 1,
Autophagy & Lysosomes ⓘ
p‑Beclin-1↑, 1, TumAuto↑, 2,
DNA Damage & Repair ⓘ
DNAdam↑, 1, P53↑, 2, PARP↓, 1,
Cell Cycle & Senescence ⓘ
CDK4↓, 1, cycD1/CCND1↓, 1, P21↑, 2, TumCCA↑, 1,
Proliferation, Differentiation & Cell State ⓘ
EMT↓, 1, FOXO3↑, 1, mTOR↓, 1, PI3K↓, 1, p‑PI3K↓, 1, TumCG↓, 6,
Migration ⓘ
Ca+2↑, 1, KRAS↓, 1, MMP2↓, 1, MMP9↓, 1, TumCI↓, 2, TumCMig↓, 3, TumCP↓, 3,
Angiogenesis & Vasculature ⓘ
angioG↓, 1, EGFR↓, 1, VEGF↓, 1,
Immune & Inflammatory Signaling ⓘ
COX2↑, 1, IL1β↓, 2, IL6↓, 1, NF-kB↓, 1, NF-kB↑, 1, TNF-α↓, 2,
Cellular Microenvironment ⓘ
e-pH↑, 1,
Drug Metabolism & Resistance ⓘ
BioAv↝, 1, ChemoSen↑, 3, Dose↓, 1, Dose↑, 1, Dose↝, 23, eff↓, 1, eff↑, 5, eff∅, 1, selectivity↑, 5,
Clinical Biomarkers ⓘ
EGFR↓, 1, GutMicro↑, 1, IL6↓, 1, KRAS↓, 1,
Functional Outcomes ⓘ
AntiCan↑, 1, AntiTum↑, 1, chemoP↑, 1, OS↑, 2, OS∅, 1, QoL↑, 1, Risk↓, 7, toxicity↓, 1, toxicity↝, 1, TumVol↓, 2, TumW↓, 1,
Infection & Microbiome ⓘ
CD8+↑, 1,
Total Targets: 104
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress ⓘ
antiOx↓, 1, NRF2↑, 1, ROS↓, 1,
Cell Death ⓘ
Casp1↓, 1,
DNA Damage & Repair ⓘ
DNArepair↑, 1,
Immune & Inflammatory Signaling ⓘ
Inflam↓, 1, NF-kB↓, 1,
Functional Outcomes ⓘ
toxicity↓, 1,
Total Targets: 8
Scientific Paper Hit Count for: Dose, Dosage
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:6 Cells:% prod#:% Target#:1114 State#:% Dir#:4
wNotes=0 sortOrder:rid,rpid
Home Page